EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Dutasteride for the Treatment of Androgenetic Alopecia: An Updated Review

Yunbu Ding, Chaofan Wang, Lingbo Bi, Yimei Du, Changpei Lu, Min Zhao, Weixin Fan

Dermatology · 2024

DOI: 10.1159/000541395 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Dermatology, 2024. Verfasst von Yunbu Ding und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China, dingyunbu@163.com. Hauptthemen laut MEDLINE: Dutasteride, Alopecia, 5-alpha Reductase Inhibitors. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 69 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Androgenetic alopecia (AGA) is a common skin disease characterized by gradually miniaturized hair follicles, which manifests as progressive hair thinning and produces a bald appearance. Currently, finasteride is approved by the Food and Drug Administration (FDA) for the treatment of AGA, but its efficacy remains poor in some patients. Summary: Compared to finasteride, oral dutasteride has better efficacy and similar tolerability, and most adverse events are mild and reversible, making it an effective option for AGA, but its sexual adverse events and potential psychiatric risks still need to be concerned. Mesotherapy with dutasteride and microneedling combined with dutasteride solution can reduce adverse events caused by oral medication and exhibit certain efficacy, but standardized treatment protocols and large-scale clinical trials are still needed in the future. Liposomes or nanoparticles of dutasteride are under development and may become an efficient topical formulation. Key Messages: We have summarized the efficacy and AEs of dutasteride in treating AGA under different administration methods and the promise of novel topical drug carriers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DutasterideAlopecia5-alpha Reductase InhibitorsHumansFinasterideAdministration, Oral

Stichwörter der Autor:innen

5α-reductase inhibitorsAndrogenetic alopeciaDutasterideFinasterideMesotherapyMicroneedling

Substanzen

Dutasteride5-alpha Reductase InhibitorsFinasteride

Autor:innen und Institutionen

  • Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China, dingyunbu@163.com.
  • Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Zitieren

APA

Ding, Y., Wang, C., Bi, L., Du, Y., Lu, C., Zhao, M., & Fan, W. (2024). Dutasteride for the Treatment of Androgenetic Alopecia: An Updated Review. Dermatology. https://doi.org/10.1159/000541395

Vancouver

Ding Y, Wang C, Bi L, Du Y, Lu C, Zhao M, et al. Dutasteride for the Treatment of Androgenetic Alopecia: An Updated Review. Dermatology. 2024. doi:10.1159/000541395

BibTeX
@article{Ding2024,
  author = {Ding, Yunbu and Wang, Chaofan and Bi, Lingbo and Du, Yimei and Lu, Changpei and Zhao, Min and Fan, Weixin},
  title = {Dutasteride for the Treatment of Androgenetic Alopecia: An Updated Review},
  journal = {Dermatology},
  year = {2024},
  doi = {10.1159/000541395}
}
Kostenlos starten →